Pharmacists in Fergus Falls, Minnesota


28 Pharmacists found in Fergus Falls
female pharmacist

Kayla Vigen, PHARM.D


Pharmacist
712 S Cascade St, Fergus Falls, MN 56537
218-736-8155    

female pharmacist

Margo Christopher


Pharmacist
712 S Cascade St, Fergus Falls, MN 56537
218-736-8199    

male pharmacist

Mark William Dewey, PHARM.D., CGP


Pharmacist - Geriatric
712 S Cascade St, Lake Region Healthcare Corp, Fergus Falls, MN 56537
218-736-8057    



female pharmacist

Mary Jane Andersen


Pharmacist
3300 Hwy 210 W, Fergus Falls, MN 56537
218-739-5559     218-739-3983

male pharmacist

Mr. Matthew Lee Kessler, PHARM.D.


Pharmacist
712 S Cascade Street, Lake Region Healthcare Corporation, Fergus Falls, MN 56537
701-388-0224    

male pharmacist

Dr. Matthew Haak, PHARMD


Pharmacist
326 W Lincoln Ave, Attn: Pharmacy, Fergus Falls, MN 56537
218-736-1028    

female pharmacist

Morgan Windhurst, PHARMD


Pharmacist
712 S Cascade St, Fergus Falls, MN 56537
218-736-8000    

female pharmacist

Renae L Lien, PHARM.D.


Pharmacist
712 Cascade St S, Lake Region Healthcare Corporation, Fergus Falls, MN 56538
651-329-8467    

male pharmacist

Scott Ronald Ward, RPH


Pharmacist
3300 State Highway 210 W, Fergus Falls, MN 56537
218-739-5559    

female pharmacist

Susan Black


Pharmacist
326 W Lincoln Ave, Fergus Falls, MN 56537
218-736-1028    

male pharmacist

Dr. Todd Arthur Johnson, PHARM.D.


Pharmacist
712 S Cascade St, Fergus Falls, MN 56537
218-736-8157    

male pharmacist

Zachary Lange


Pharmacist
1205 W Lincoln Ave, Fergus Falls, MN 56537
218-739-3259    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.